Budesonide Induces Remission More Effectively Than Prednisone in a Controlled Trial of Patients With Autoimmune Hepatitis
- 1 October 2010
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 139 (4) , 1198-1206
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Diagnosis and Management of Autoimmune HepatitisHepatology, 2010
- Special Clinical Challenges in Autoimmune Hepatitis: The Elderly, Males, Pregnancy, Mild Disease, Fulminant Onset, and Nonwhite PatientsSeminars in Liver Disease, 2009
- Budesonide in previously untreated autoimmune hepatitisLiver International, 2005
- International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitisJournal of Hepatology, 1999
- Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitisJournal of Hepatology, 1999
- Oral budesonide for treatment of autoimmune chronic active hepatitisAlimentary Pharmacology & Therapeutics, 1994
- Significance of HLA DR4 in type 1 autoimmune hepatitisGastroenterology, 1993
- CHARACTERISATION OF A NEW SUBGROUP OF AUTOIMMUNE CHRONIC ACTIVE HEPATITIS BY AUTOANTIBODIES AGAINST A SOLUBLE LIVER ANTIGENThe Lancet, 1987
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981
- CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITISThe Lancet, 1973